TELA Bio FY2026 Revenue expected to be more than $86.697M vs $92.674M Est

Benzinga Newsdesk www.benzinga.com Positive 78.4%

Neg 0% Neu 0% Pos 78.4%

TELA Bio (NASDAQ:TELA) FY2026 Revenue expected to be more than $86.697M vs $92.674M Est

Comments

No comments yet. Be the first!